Legend Biotech Corporation (LEGN)

Legend Biotech Stock Forecast

Stock Price Forecast

The 13 analysts that cover Legend Biotech stock have a consensus rating of "Buy" and an average price target of $64.23, which forecasts a 274.52% increase in the stock price over the next year. The lowest target is $21 and the highest is $90.

Price Target: $64.23 (+274.52%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$64.23	$71	$90
Change	+22.45%	+274.52%	+313.99%	+424.78%

Analyst Ratings

The average analyst rating for Legend Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	4	4	4	4	4	4
Buy	7	7	7	8	8	8
Hold	1	1	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	13	13	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $60 → $50	Strong Buy	Maintains	$60 → $50	+191.55%	Jan 22, 2026
Yaron Werber TD Cowen	TD Cowen	Strong Buy → Hold Downgrades $62 → $21	Strong Buy → Hold	Downgrades	$62 → $21	+22.45%	Jan 22, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $66	Buy	Maintains	$66	+284.84%	Jan 20, 2026
Trevor Allred Oppenheimer	Oppenheimer	Buy Initiates $75	Buy	Initiates	$75	+337.32%	Jan 7, 2026
Eric Schmidt Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $75 → $74	Buy	Maintains	$75 → $74	+331.49%	Dec 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.05B

Increased by 67.56%

from 627.24M

Revenue Next Year

1.53B

Increased by 45.77%

from 1.05B

EPS This Year

-0.90

from -0.97

EPS Next Year

0.40

from -0.90

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	75.00M	68.83M	117.01M	285.14M	627.24M	1.05B	1.53B
Revenue Growth	21.36%	-8.23%	70.00%	143.70%	119.97%	67.56%	45.77%
EPS	-2.26	-2.87	-2.81	-2.94	-0.97	-0.90	0.40
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	42.88
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	1.8B
Avg	1.1B	1.5B
Low	976.1M	1.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	82.5%	75.1%
Avg	67.6%	45.8%
Low	55.6%	22.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.41	1.04
Avg	-0.90	0.40
Low	-1.61	-0.04

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.